THE HYDRATION PHARMACEUTICALS COMPANY LIMITED
ASX:HPCHousehold & Personal ProductsToday’s holders own 79.4% of what they think they own, once every option and right converts.
Runway under 2 quarters; share count grew 73% in 24 months; 5 cash raises in 24 months
THE HYDRATION PHARMACEUTICALS COMPANY LIMITED had an ordinary share count of 538M as of June 2026; the filed 2A series ends earlier, so share-count change over that period is not stated. The company raised capital five times in the 24‑month window, total proceeds A$3.1M, most recently a non‑renounceable pro‑rata entitlement offer in October 2026 raising A$1.4M. Options and rights on issue could convert into 139M new shares, a 25.9% overhang, all out of the money, with the nearest expiry in December 2026. No funding‑runway figure applies because the reported cash would have been used up and no later cash report is on record. One proposed securities issue (Appendix 3B) is pending, expected in November 2026.
Quick answers · 4
Is HPC raising capital?
The Hydration Pharmaceuticals Company has 1 proposed issue of securities pending under Appendix 3B as at 28 Oct 2026; the most recent raise announced is Non-renounceable pro rata entitlement offer (Rights Issue) of $1.4M on 23 Oct 2026.
How much placement capacity does HPC have left?
None of the 15% placement capacity counted as used in the last 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.
How much cash does HPC have?
In its quarterly cash report for the quarter ended 30 June 2026, The Hydration Pharmaceuticals Company reported $643k of cash and estimated 1.3 quarters of funding available at its current rate of spending. That is the company's own estimate.
When do HPC's options expire?
Unexercised options and rights equal 25.9% of The Hydration Pharmaceuticals Company's shares on issue; the nearest expiry is Dec 2026.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 23 June 2026 | 2A · quoted issue | HPC : ORDINARY FULLY PAID | 528.8M | Appendix 2A |
| 23 June 2026 | 2A · quoted issue | HPC : ORDINARY FULLY PAID | 440.0M | Appendix 2A |
| 7 Jan 2026 | 3H · cancellation | HPC : ORDINARY FULLY PAID | 430.8M | Appendix 3H |
| 6 Oct 2025 | 3H · cancellation | HPC : ORDINARY FULLY PAID | 430.8M | Appendix 3H |
| 10 July 2025 | 2A · quoted issue | HPC : ORDINARY FULLY PAID | 430.8M | Appendix 2A |
Each filing states the count for the security it names, as at its own reference date and in the units of that filing — so the newest row (528.8M) need not equal the current count above (538.0M).
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
5 cash raises in the last 24 months · 2 in the last 12 months
Retail offer
An offer existing holders can take part in — the one structural advantage retail has in a raise. Dated recently and not yet recorded as complete.
Closing dates are not in the filings this site holds. Check the company's own announcement below before acting on this.
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
An exercise price is on record for only 28.3% of this supply, so what is in the money today is not a measurement — the tile above reads “—” for that reason. Of the priced supply, 0 is in the money at $0.0030 today. No more priced supply until 10× today’s price, which takes it to 16.6M (3.1% of shares).
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
- 99.9M (71.7% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
- 22.8M more carries an exercise price above ten times today’s — off the right of this axis, and in every total on this page.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| HPCAAA | Options | Price-triggered | $0.29 | 1 Dec 2026 | 306k | Filing |
| HPCAH | Options | Price-triggered | $0.29 | 1 Dec 2026 | 2.0M | Filing |
| HPCAAB | Options | Price-triggered | $0.44 | 1 Dec 2026 | 62k | Filing |
| HPCAAC | Options | Price-triggered | $0.58 | 1 Dec 2026 | 62k | Filing |
| HPCAAD | Options | Price-triggered | $0.73 | 1 Dec 2026 | 62k | Filing |
| HPCAQ | Options | Price-triggered | $0.47 | 22 July 2027 | 107k | Filing |
| HPCAV | Options | Price-triggered | $0.043 | 29 Aug 2028 | 14.7M | Filing |
| HPCAO | Options | Price-triggered | $1.34 | 14 Sept 2028 | 957k | Filing |
| HPCAI | Options | Price-triggered | $0.45 | 13 Jan 2029 | 2.6M | Filing |
| HPCAAE | Options | Price-triggered | $0.016 | 1 Mar 2029 | 16.6M | Filing |
| HPCAJ | Options | Price-triggered | $0.45 | 30 Apr 2029 | 179k | Filing |
| HPCAK | Options | Price-triggered | $0.45 | 2 May 2029 | 713k | Filing |
| HPCAR | Warrants | Price-triggered, no exercise price stated | — | — | 99.9M | Filing |
| HPCAP | Options | Price-triggered | $0.45 | — | 1.1M | Filing |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 31 Dec 2025 | Adem Karafili | Sell | 2.6M | 75k | — | — | 3Y notice |
| 31 Dec 2025 | Margaret Hardin | Sell | 372k | 54k | — | — | 3Y notice |
| 31 Dec 2025 | Nicholas Berry | Sell | 73.1M | 52.4M | — | — | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.